Emerging Neurobiology of Antidepressant Treatments

Michael Browning, Philip J. Cowen, Trevor Sharp (Herausgeber)

Buch | Hardcover

2024 | 2024
Springer International Publishing (Verlag)
978-3-031-66355-0 (ISBN)

Noch nicht erschienen - erscheint am 06.09.2024
Versandkostenfrei
innerhalb Deutschlands
Auch auf Rechnung
Verfügbarkeit in der
Filiale vor Ort prüfen

Artikel merken

This volume is unique in bringing the exciting range of antidepressant treatment developments together with a focus on their neurobiological mechanisms and how these interact with the known pathophysiology of depression. Current evidence for treatment efficacy is reviewed together with a discussion of where in the management pathway of this common condition, these new approaches might take their place.

SSRIs A pharmacological cul-de-sac.- Neurobiology of SSRI withdrawal.- Pramipexole in the treatment of depression.- Opioid mechanisms in the treatment of depression.- Neuropsychological effects of antidepressants-translational studies.- KETAMINE FOR MAJOR DEPRESSIVE DISORDER.- Psilocybin and other classic psychedelics in depression.- Gut-brain axis and antidepressant treatment.- Anti-inflammatory drugs in the treatment of depression.- Mechanisms of TMS in Depression.- Mechanism of action of ECT in depression.- Vagal nerve stimulation in the treatment of depression.

Erscheint lt. Verlag	6.9.2024
Reihe/Serie	Current Topics in Behavioral Neurosciences
Zusatzinfo	Approx. 400 p. 100 illus., 30 illus. in color.
Verlagsort	Cham
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie
	Medizin / Pharmazie ► Studium
	Naturwissenschaften ► Biologie ► Humanbiologie
Schlagworte	antidepressants • brexanolone • Depression • ECT • Ketamine • Opiates • orexins • pramipexole • Probiotics • Psilocybin • SSRIs • TMS • VNS
ISBN-10	3-031-66355-1 / 3031663551
ISBN-13	978-3-031-66355-0 / 9783031663550
Zustand	Neuware